Migraine and tension-type headache treated with stromal vascular fraction: a case series
Open Access
- 30 June 2014
- journal article
- case report
- Published by Springer Nature in Journal of Medical Case Reports
- Vol. 8 (1) , 237
Abstract
Chronic migraines and tension-type headaches are debilitating diseases affecting 1.4 to 2.2% of the population with both quality of life and economic implications. To date, the pain associated with migraine and tension-type headaches has been controlled with a range of medications, with varying levels of success. In addition, the side-effect profile of these medications, as well as their potential for addiction, has been a cause for concern for both patients and physicians.Keywords
This publication has 15 references indexed in Scilit:
- Concise Review: Endothelial Stem and Progenitor Cells and Their HabitatsStem Cells Translational Medicine, 2013
- Pathophysiology of MigraineAnnual Review of Physiology, 2013
- Central nervous system acting drugs in treatment of migraine headache.Central Nervous System Agents in Medicinal Chemistry, 2012
- Autologous stromal vascular fraction therapy for rheumatoid arthritis: rationale and clinical safetyInternational Archives of Medicine, 2012
- Sensitization of the Trigeminovascular Pathway: Perspective and Implications to Migraine PathophysiologyJournal of Clinical Neurology, 2012
- Non-expanded adipose stromal vascular fraction cell therapy for multiple sclerosisJournal of Translational Medicine, 2009
- Mesenchymal stem cells in health and diseaseNature Reviews Immunology, 2008
- Tension-type headache: current research and clinical managementThe Lancet Neurology, 2008
- Response Properties of Dural Nociceptors in Relation to HeadacheJournal of Neurophysiology, 2006
- Sensitization of meningeal sensory neurons and the origin of headachesNature, 1996